GCG and diabetic retinopathy: Based on several preclinical trials, GLP-1 and its agonists have a protective effect against diabetic retinopathy through their antiapoptotic and anti-inflammatory mechanisms by reversing and inhibiting early changes, such as neurodegeneration and BRB permeability [18].